ReviewJournal of hepatocellular carcinoma2022

Trial Designs for Integrating Novel Therapeutics into the Management of Intermediate-Stage Hepatocellular Carcinoma.

Yung-Yeh Su et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.